Actinium Pharmaceuticals, Inc. (ATNM)

Free Cash Flow

-$23.25M

TTM · Period ending: · USD

ATNM logo

ATNM Free Cash Flow

Latest reported-$23.25M
ATNM TTM Free Cash Flow (-$15.49K → -$23.25M)
High-resolution chart · PNG

ATNM free cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Actinium Pharmaceuticals, Inc. Free Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFree Cash Flow (USD)
-23,247,000
-22,982,000
-24,684,000
-25,042,000
-30,692,000
-33,272,000
-33,083,000
-34,822,000
-34,002,000
-39,720,000
-47,488,000
-47,792,000
-42,425,000
-1,087,000
8,278,000
11,020,000
11,152,000
-21,141,000
-20,999,000
-22,450,000
-21,796,000
-21,662,000
-21,870,000
-20,381,844
-20,978,850
-21,839,076
-21,525,830
-20,808,439
-21,882,153
-20,741,667
-20,667,148
-19,539,477
-18,743,525
-21,661,075
-21,578,085
-22,666,394
-22,361,007
-21,448,383
-20,849,197
-20,576,212
-18,530,077
-17,562,565
-18,591,556
-19,654,632
-20,391,135
-17,820,845
-14,500,442
-10,805,269
-8,170,587
-6,488,205
-6,309,008
-10,156,228
-8,531,556
-7,523,168
-5,216,881
-21,068
-22,187
-6,018
-2,975
-3,634
-13,301
9,139
7,835
9,762
17,713
-13,957
-18,783
-18,659
-18,283
-21,152
-13,964
-15,439
-15,238
-15,054
-15,492
-14,997
-20,374
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.